Prognostic properties of anti-topoisomerase antibodies in patients identified by the ACR/EULAR 2013 systemic sclerosis criteria

Rheumatology (Oxford). 2019 Apr 1;58(4):730-732. doi: 10.1093/rheumatology/kez005.

Authors

Maaike Boonstra¹, Maarten K Ninaber², Nina Ajmone Marsan³, Tom W J Huizinga¹, Hans Ulrich Scherer¹, Jeska K de Vries-Bouwstra¹

Affiliations

¹ Department of Rheumatology, Leiden University Medical Center, Leiden, The Netherlands.
² Department of Pulmonology, Leiden University Medical Center, Leiden, The Netherlands.
³ Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.

PMID: 30690619
DOI: 10.1093/rheumatology/kez005

No abstract available

Publication types

Letter

MeSH terms

Adult
Autoantibodies / blood*
Biomarkers / blood
DNA Topoisomerases / immunology*
Female
Humans
Male
Middle Aged
Prognosis
Rheumatology / methods
Rheumatology / statistics & numerical data*
Scleroderma, Systemic / immunology*
Severity of Illness Index*

Substances

Autoantibodies
Biomarkers
DNA Topoisomerases